World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
23111
World Ranking
1273
National Ranking
566

Medicine

D-Index
78
Citations
23092
World Ranking
18017
National Ranking
8982

Raphael P. Viscidi publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Raphael P. Viscidi sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 262 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Raphael P. Viscidi D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Raphael P. Viscidi sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Raphael P. Viscidi is affiliated with Johns Hopkins University in the United States, contributing to research primarily within the fields of Medicine and Immunology and Microbiology. Their work spans multiple subfields including Epidemiology, Infectious Diseases, Molecular Biology, Immunology, and Otorhinolaryngology.

The scientist's research topics cover a range of interconnected areas, notably:

  • Cervical Cancer and HPV Research
  • COVID-19 Clinical Research Studies
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • Inflammasome and immune disorders
  • Head and Neck Cancer Studies
  • Oral Health Pathology and Treatment

Raphael P. Viscidi has authored papers published in several scientific journals, including multiple contributions to the European Journal of Immunology and the Journal of Virology. Other publication venues include The Journal of Infectious Diseases, Cancer Prevention Research, and Clinical Infectious Diseases.

Selected recent papers authored or co-authored by the scientist include:

  • Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity (2022), published in European Journal of Immunology
  • Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior (2020), published in The Journal of Infectious Diseases
  • An Integrated Approach for Preventing Oral Cavity and Oropharyngeal Cancers: Two Etiologies with Distinct and Shared Mechanisms of Carcinogenesis (2020), published in Cancer Prevention Research
  • Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice (2020), published in Journal of Virology
  • Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV) (2020), published in Clinical Infectious Diseases

The scientist collaborates frequently with other researchers. Notable co-authors include Guido Antonelli, Carolina Scagnolari, Federica Frasca, Alessandra Pierangeli, and Gabriella d'Ettorre, with multiple joint publications among these colleagues.

Best Publications

  • Case-control study of human papillomavirus and oropharyngeal cancer.

    Aimee R. Kreimer;Raphael Viscidi;Michael Pawlita;Carole Fakhry

  • Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

    Maura L. Gillison;Gypsyamber D'Souza;William Westra;Elizabeth Sugar

  • Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

    Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska

  • Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations

    Raphael Viscidi;Raphael Viscidi;Raphael Viscidi;Sandra Willey;Sandra Willey;Sandra Willey;John G. Bartlett;John G. Bartlett;John G. Bartlett

  • ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PRESENTATION OF ANTIGENS

    Tzyy-Choou Wu;F. G. Guarnieri;K. F. Staveley-O'carroll;R. P. Viscidi

  • Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy

    Rebecca M. Brotman;Michelle D. Shardell;Pawel Gajer;Doug Fadrosh

  • Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1

    Raphael P. Viscidi;Kumudini Mayur;Howard M. Lederman;Alan D. Frankel

  • Clinician's guide to human papillomavirus immunology: knowns and unknowns.

    Mark H Einstein;John T Schiller;Raphael P Viscidi;Howard D Strickler

  • Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships

    T.C. Quinn;C. Gaydos;M. Shepherd;L. Bobo

  • Serum Antibody Response to Toxins A and B of Clostridium difficile

    R. Viscidi;B. E. Laughon;R. Yolken;P. Bo-Linn

  • Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy

    Unknown

  • Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica

    Raphael P. Viscidi;Mark Schiffman;Allan Hildesheim;Rolando Herrero

  • Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

    Tae Woo Kim;Jin Hyup Lee;Chien Fu Hung;Shiwen Peng

  • A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

    Cornelia L. Trimble;Shiwen Peng;Ferdynand Kos;Patti Gravitt

  • Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada

    Javier Pintos;Martin J. Black;Nader Sadeghi;Parviz Ghadirian

  • Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus

    Raphael P. Viscidi;Dana E. Rollison;Vernon K. Sondak;Barbara Silver

  • Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab

    Yiping Chen;Evelyn Bord;Troy Tompkins;Janice Miller

  • Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms

    Emily G. Severance;Faith B. Dickerson;Raphael P. Viscidi;Ioannis Bossis

  • Population genetics of microbial pathogens estimated from multilocus sequence typing (MLST) data

    Marcos Pérez-Losada;Emily B. Browne;Aaron Madsen;Thierry Wirth

  • Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.

    Martin Moller;Raphael P. Viscidi;Yeping Sun;Eloisa Guerrero

  • Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays

    Raphael P. Viscidi;Dana E. M. Rollison;Emma Viscidi;Barbara Clayman

Frequent Co-Authors

Robert H. Yolken
Robert H. Yolken Johns Hopkins University
Keerti V. Shah
Keerti V. Shah Johns Hopkins University
Patti E. Gravitt
Patti E. Gravitt National Institutes of Health
Anna R. Giuliano
Anna R. Giuliano University of South Florida
Igor J. Koralnik
Igor J. Koralnik Northwestern University
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Robert D. Burk
Robert D. Burk Albert Einstein College of Medicine
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Keith A. Crandall
Keith A. Crandall George Washington University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing microbiology, exploring related online degrees can open diverse career opportunities in health, research, and applied sciences. Many professionals consider flexible options like the best easiest mph online programs to get into to advance their understanding of public health without intense entry barriers.

Additionally, there are specialized roles such as becoming a child life specialist, where knowledge of biology and human development plays a critical role. Those interested can learn more about the child life specialist salary and the credentials required to enter this rewarding career path.

It's also worth noting that online degrees can offer accessible pathways for individuals with diverse backgrounds. Programs highlighted under college degrees for felons provide valuable second chances to those seeking education and new careers despite past challenges.

Healthcare-focused careers remain popular, with fields like functional medicine growing rapidly. For microbiology graduates looking to pivot, the role of a functional medicine np offers a unique blend of clinical practice and holistic care.

Best Scientists Citing Raphael P. Viscidi

Trending Scientists

Recently Published Articles